Information behaviour of Canadian pharmaceutical policy makers

Health Information and Libraries Journal
Devon L GreysonSteve Morgan

Abstract

Understanding the information behaviour of policy makers targeted by knowledge translation efforts is key to improving policy research impact. This study explores the reported information behaviour of pharmaceutical policy decision-makers in Canada, a country highly associated with evidence-based practice yet still facing substantial barriers to evidence-informed health policy. We conducted semi-structured telephone interviews with a purposive sample of 15 Canadian pharmaceutical policy decision-makers. Results of the descriptive, qualitative analysis were compared with the General Model of Information Seeking of Professionals (GMISP) proposed by Leckie, Pettigrew and Sylvain in 1996. Characteristics of information needs included topic, depth/breadth of questions and time sensitivity. Approaches to information seeking were variously scattershot, systematic and delegated, depending on the characteristics as well as respondent resources. Major source types were human experts, electronic sources and trusted organisations. Affective (emotion-related) outcomes were common, including frustration and desire for better information systems and sources. The GMISP model may be adapted to model information behaviour of Canadian pharmaceuti...Continue Reading

References

Jan 1, 1990·Journal of Health Politics, Policy and Law·J Lomas
Feb 26, 1997·JAMA : the Journal of the American Medical Association·J Lewin
Dec 17, 1998·Journal of Urban Health : Bulletin of the New York Academy of Medicine·P W O'CarrollC R Selden
Dec 17, 1998·Journal of Urban Health : Bulletin of the New York Academy of Medicine·C Lynch
Dec 17, 1998·Journal of Urban Health : Bulletin of the New York Academy of Medicine·R D Lasker
Aug 15, 2000·Research in Nursing & Health·M Sandelowski
Nov 12, 2002·Journal of Health Services Research & Policy·Simon InnvaerAndrew Oxman
Feb 7, 2003·Social Science & Medicine·Renée Gravois Lee, Theresa Garvin
Mar 21, 2003·Health Research Policy and Systems·Stephen R HanneyMaurice Kogan
Jul 5, 2003·The Milbank Quarterly·John N LavisUNKNOWN Knowledge Transfer Study Group
Aug 12, 2003·International Journal of Medical Informatics·Martin Dawes, Uchechukwu Sampson
Jul 1, 1954·Psychological Bulletin·J C FLANAGAN
Mar 1, 1956·Psychological Review·H A SIMON
Jul 27, 2004·Journal of Health Services Research & Policy·Craig Mitton, San Patten
Aug 2, 2005·Journal of Health Services Research & Policy·John LavisEwan Ferlie
Feb 18, 2006·Journal of Health Politics, Policy and Law·Patricia M Pittman
Mar 25, 2006·The Journal of Continuing Education in the Health Professions·Ian D GrahamNicole Robinson
Mar 25, 2006·The Journal of Continuing Education in the Health Professions·Carole A EstabrooksAnne Hofmeyer
Jun 23, 2007·Health Information and Libraries Journal·Karen Davies, Janet Harrison
Nov 2, 2011·Healthcare Policy = Politiques De Santé·Steve Morgan, Colleen M Cunningham
Apr 1, 1986·The Behavior Analyst·T Seekins, S B Fawcett

❮ Previous
Next ❯

Citations

Feb 18, 2012·Health Information and Libraries Journal·Maria J Grant
Jan 5, 2014·BMC Health Services Research·Kathryn OliverJames Thomas
Jul 15, 2015·European Journal of Public Health·Kathryn A OliverMartin Everett
Mar 8, 2018·Cadernos de saúde pública·Ana Paula Cavalcante de OliveiraGilles Dussault
Oct 4, 2017·Health Research Policy and Systems·Kristel AllaCarla S Meurk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.